tiprankstipranks
Trending News
More News >
Nanobiotix SA (GB:0QAV)
LSE:0QAV

Nanobiotix (0QAV) Similar Shares

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Nanobiotix
€18.36
€832.03M
-23.47
495.71%
3 Buy
0 Hold
0 Sell
Strong Buy
Genfit
€5.20
$179.33M
-4.62
46.07%
1 Buy
0 Hold
0 Sell
Moderate Buy
Innate Pharma SA
€1.62
€151.53M
4.25%
0 Buy
1 Hold
0 Sell
Hold
Abivax SA
€115.80
€6.87B
-31.59
1456.45%
1 Buy
0 Hold
0 Sell
Moderate Buy
DBV Technologies
€3.45
€470.02M
-2.76
396.40%
1 Buy
0 Hold
0 Sell
Moderate Buy
OSE Immunotherapeutics SA
€4.97
€128.53M
-3.62
-37.62%
0 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0QAV
Nanobiotix
19.98
16.70
508.40%
FR:GNFT
Genfit
5.20
1.63
45.45%
FR:IPH
Innate Pharma SA
1.67
0.12
7.61%
FR:ABVX
Abivax SA
115.80
108.36
1456.45%
FR:DBV
DBV Technologies
3.45
2.76
396.40%
FR:OSE
OSE Immunotherapeutics SA
4.97
-3.24
-39.44%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts